Folic acid-targeted iron oxide nanoparticles as contrast agents for magnetic resonance imaging of human ovarian cancer

被引:0
作者
He Zhang
Jingchao Li
Yong Hu
Mingwu Shen
Xiangyang Shi
Guofu Zhang
机构
[1] Obstetrics and Gynecology Hospital,Department of Radiology
[2] Fudan University,College of Chemistry, Chemical Engineering and Biotechnology
[3] Donghua University,undefined
来源
Journal of Ovarian Research | / 9卷
关键词
Ovarian cancer; Iron oxide nanoparticles; Folic acid; Targeting; Magnetic resonance imaging;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 154 条
[1]  
Moyle P(2010)Radiological staging of ovarian carcinoma Semin Ultrasound CT MR 31 388-398
[2]  
Addley HC(2012)Bevacizumab and ovarian cancer Curr Opin Obstet Gynecol 24 8-13
[3]  
Sala E(2004)Focus on epithelial ovarian cancer Cancer Cell 5 19-24
[4]  
Sato S(2011)Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients Ann Oncol 22 1346-1352
[5]  
Itamochi H(2012)Ovarian cancer, version 3.2012 J Natl Compr Canc Netw 10 1339-1349
[6]  
Ozols R(2011)Phase II study of intraperitoneal paclitaxel plus cisplatin and intravenous paclitaxel plus bevacizumab as adjuvant treatment of optimal stage II/III epithelial ovarian cancer J Clin Oncol 29 4662-4668
[7]  
Bookman M(1995)Adnexal masses: accuracy of characterization with transvaginal US and precontrast and postcontrast MR imaging Radiology 194 557-565
[8]  
Connolly D(2000)Complex adnexal masses: detection and characterization with MR imaging-multivariate analysis Radiology 214 39-46
[9]  
Vencken P(2014)Prospective evaluation of 3T MRI findings for primary adnexal lesions and comparison with the final histological diagnosis Arch Gynecol Obstet 289 357-364
[10]  
Kriege M(2011)Targeted dual-contrast T Biomaterials 32 4584-4593